250 words) 21 Phages are natural predators of bacteria and have been exploited in bacterial detection because of 22 their exquisite specificity to their cognate bacterial hosts. In this study, we present a 23 bacteriophage amplification-coupled assay as a surrogate for detecting a bacterium present in a 24 sample. The assay entails detection of progeny phage resulting from infection and subsequent 25 growth inside the bacterium present in suspected samples. This approach reduces testing time 26 and enhances sensitivity to identify pathogens compared to traditional overnight plaque assay.
Text (3000 words) 43 Introduction 44 Early diagnosis of an etiological agent is paramount in implementing timely and appropriate 45 countermeasures to prevent fatal consequences. In an outbreak scenario, protecting the patients 46 and preventing further dissemination of the disease relies on early, rapid, accurate and sensitive 47 detection of the infectious agent. This in turn relies on the assay and detection platform used. 48 Currently, four broad categories of biodetection systems are available. 1) Microbiological/ 49 biochemical tests, 2) antibody based, 3) nucleic acid based and 4) other methods including mass 50 spec and bioluminescence. The length of assay times and levels of purification of the sample to 51 be tested vary widely with these systems. Conventional microbiological culturing and staining, 52 differential growth of target organisms in selective media require live cells and take time 53 anywhere from 16 hours to several days in some cases, prior to definitive identification of the 54 culprit organisms (1).
55
There are some drawbacks with the antibody or nucleic acid based systems. For example, PCR 56 and nucleic acid sequence-based amplification (NASBA) enrich a single specific piece of DNA 57 or RNA sequence up to 10 6 -fold in 20 minutes to a few hours and theoretically have a sensitivity 58 of a single bacterial cell. The PCR methods give rapid, specific detection but are limited by small 59 sample volumes (e.g., 5 l for PCR). Furthermore, substances in the sample matrix may inhibit 60 the PCR reaction and the steps used to concentrate the sample to obtain enough templates for 61 PCR may concentrate the inhibitors as well. Immunoassays are based on the concept that any 62 compound that is capable of triggering an immune response can be targeted as an antigen and 63 have been used not only for all types of agents including spores, toxins, and viruses. In general,
64
PCR is much more sensitive than immuno-assays (1). These NASBA and immunoassays cannot 65 discriminate between live and dead target pathogens.
66
There is another paradigm that takes advantage of phages for bacterial detection. Phages are 67 bacterial viruses and are specific to each bacterial species they infect and sometimes, even strains 68 of a given species. The kinetics of interaction between bacteria and their cognate phages is 69 comparable to that of antigen-antibody interaction, making them highly suitable for bacterial 70 detection (2, 3). In addition, the phage-bacterial specificity has evolved over millions of years 71 making them as good as or even better than antigen-antibody specificity. The specificity is 72 attributed to a receptor on the surface of phage that interacts with a receptor on the bacterial 73 surface and this pair is unique. This specificity has been used to develop phage-typing schemes 74 for bacterial species and strains (4-9). Moreover, the cost incurred in producing a phage-based 75 detection reagent is relatively inexpensive compared to the antigen-antibody based reagents. In 76 addition, phages can be useful in deciphering viability of a bacterial pathogen in the sample and 77 furthermore, replication of phage inside the bacterium leads to an amplification of the detection 78 signals thus increasing the sensitivity of the assay.
79
A number of detection systems exploiting phage-bacterial specificity have been developed for 80 different bacteria (10). One of the earliest phage based detection systems involved incorporation 81 of lux genes in a mycobacterial phage genome. Expression of the lux genes in susceptible 82 mycobacterial cells emitted luminescence signals captured by a handheld Polaroid camera device 83 termed "bronx-box" (11). Similar approaches have been taken for construction of recombinant 84 phages for the detection of Bacillus anthracis and Yersinia pestis (12, 13) . Another elegant 85 fluorescence technique, designed to detect deadly E. coli O157:H7 bacteria, relied on 86 introducing green fluorescent protein (gfp) gene via a bacteriophage. Expression of phage-87 encoded gfp inside the bacterium emits fluorescence that can be measured in a flow cytometer 88 (14). These methods involved extensive genetic manipulation and relatively expensive 89 fluorescent measurement instruments. There are other limitations to this approach: a) level of 90 expression of LUX/GFP is dependent on the phage promoter that controls its expression; b) low 91 photostability of GFP permits fluorescence measurement only for a few seconds to a minute 92 under normal microscopic conditions and therefore, renders the quantitative fluorescence assay 93 difficult in GFP expressed cells. In order to improve the sensitivity and potential for multiplexing, 94 phage-quantum dot assays for rapid high-sensitive detection of bacterial pathogens have been 95 described (15, 16) . Although phage-quantum dot approach has certain advantages in 96 multiplexing and increased sensitivity, appropriate instruments for measuring multiplex 97 fluorescence signals are not available and thus are not field deployable.
98
Previous studies have demonstrated the utility of phage amplification coupled-detection assay in 99 a simple platform such as lateral flow immunoassay (LFI) and showed reasonable detection 
Results

118
Determination of assay linearity of phage MS2 based MAGPIX immunoassay 119
The capture sandwich immunoassay for MS2 phage on the MAGPIX platform was developed 120 using polyclonal anti MS2 antibodies. In the assay, target antigen (MS2) is captured by 121 antibodies (anti MS2 antibodies) coupled on the surface of beads, followed by quantification of 122 the bead bound complex by labeled antibodies. Thus, an increase in progeny phage; i.e., phage 123 amplification can be correlated with amplification in fluorescence signal. The concept of using 124 MAGPIX instrument for this assay is illustrated in Figure 1 . 125 The phage MAGPIX assay, as an indirect measurement of bacterial detection, is incumbent upon 126 detection of progeny phages rather than the input phage used to initiate infection. Therefore, the 127 input phage concentration should be low enough (below the detection limits of the instrument) so 128 that upon phage amplification there is high enough phage titer to result in significant signal 129 amplification that can be detected. Also, it should not be too low, in which case the assay would 130 require longer incubation times to produce high enough phage titers that would generate 131 measureable fluorescence signal intensities. In order to determine the appropriate initial MS2 132 concentration, the linearity of the MS2 MAGPIX assay was assessed. A dose response curve of 133 the assay was generated by serial dilution of MS2 in LB media and measuring the median 134 fluorescence intensity (MFI). A clear linearity of signal intensity was seen at phage 135 concentrations ranging from 1×10 6 pfu/ mL to 1×10 9 pfu/ mL ( Figure 2 ). Thus, initial MS2 136 concentration to assess the signal amplification in the assay based on phage replication was 137 determined to be 1×10 6 pfu/mL. Figure 4) . Furthermore, the MFI was increased significantly in samples containing E. coli at 155 1×10 2 cells/mL after 3-hour incubation and thus establishing a limit of detection for this assay.
156
The limit of detection is defined by a signal greater than the mean background MFI plus three 157 standard deviations. Higher concentrations of E. coli (10 5 -10 6 CFU/ml) produced signal 158 intensities that allowed detection in shorter incubation times; i.e., 1 hour where almost 9-fold 159 increase was observed with 10 5 cells/ml compared to 10 3 cells/ml. Also, in a clinical or point of care/field setting such a discrimination ability and phage mediated 199 signal amplification will be very useful for determining antibiotic sensitivity rapidly. For 200 example, in slow growing bacteria like Mycobacterium spp such an approach has been used to 201 test antibacterial susceptibility in the field (11). Also, these technologies are limited in their 202 potential for multiplexing and high throughput analysis. To address these two gaps, as a proof of 203 concept, we developed a phage based live agent detection assay using MAGPIX instrument.
204
Phage MS2 is an E. coli male specific phage because of its specificity to infect only strains that 205 carry the F pilus (21). MS2 has a burst size of 5000-10000 per infected cell (22) to published immunoassays for E. coli detection (24, 25). The limit of detection of this assay is 213 dependent on the burst size of a given phage in its specific bacterial host. Phages with high burst 214 will yield large number of progeny particles that will yield correspondingly high signal intensity 215 in the MAGPIX assay. However, for phages with low burst size, a large number of bacteria 216 should be present during initial infection, in order to yield high enough signal intensity above the 217 background to make a positive call. The optimal multiplicity of infection needs to be determined 218 for each phage-bacterium combination since the initial bacterial load in each sample may vary.
219
Intuitively, it would seem phage-based assays are not available for other types of agents such as 220 spores, viruses and toxins. However, using M13 like phages, one can pan for phages with peptide 221 displays that bind specifically to these biothreats and add that to the MAGPIX panel of assays.
222
Despite these limitations, our future efforts will focus on developing a phage multiplex MAGPIX 223 assay panel to target bacterial, viral and toxin threats. 
